DROZ DIT BUSSET, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 313
NA - Nord America 260
AS - Asia 94
SA - Sud America 1
Totale 668
Nazione #
US - Stati Uniti d'America 254
GB - Regno Unito 139
CN - Cina 70
IT - Italia 58
SE - Svezia 45
DE - Germania 25
DK - Danimarca 20
IN - India 9
BE - Belgio 6
CA - Canada 6
HK - Hong Kong 6
UA - Ucraina 6
FR - Francia 3
JP - Giappone 3
ES - Italia 2
ID - Indonesia 2
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
GR - Grecia 1
HR - Croazia 1
KH - Cambogia 1
NL - Olanda 1
NO - Norvegia 1
PH - Filippine 1
RO - Romania 1
TR - Turchia 1
VN - Vietnam 1
Totale 668
Città #
Southend 134
Chandler 44
Milan 32
Ann Arbor 31
Dearborn 25
Fairfield 23
Wilmington 20
Princeton 18
Nanjing 17
Andover 10
Grafing 10
Beijing 8
Des Moines 8
Houston 8
Cambridge 7
Woodbridge 7
Brussels 6
Central District 6
Redwood City 6
Seattle 6
Shanghai 6
Shenyang 5
Changsha 4
San Diego 4
Fremont 3
Guangzhou 3
Hebei 3
Hefei 3
Jinan 3
Toronto 3
Zhengzhou 3
Berlin 2
Boardman 2
Chicago 2
Jiaxing 2
Mountain View 2
Napoli 2
Ningbo 2
Ottawa 2
Parabiago 2
Roxbury 2
San Giuliano Milanese 2
Angeles City 1
Ashburn 1
Carol Stream 1
Chelmsford 1
Chengdu 1
Ciampino 1
Delhi 1
Durrës 1
Fuzhou 1
Hangzhou 1
Hanoi 1
La Canada Flintridge 1
London 1
Los Angeles 1
Madrid 1
Malatya 1
Nanchang 1
New Haven 1
New York 1
North Bergen 1
Pedara 1
Phnom Penh 1
Phoenix 1
Providence 1
Quzhou 1
Redmond 1
Ribera 1
Rijeka 1
Rotterdam 1
Silver Spring 1
Sofia 1
Solbiate Olona 1
Stavanger 1
Tianjin 1
Vienna 1
Winnipeg 1
Totale 524
Nome #
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula : A Prospective Clinical Study 133
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA) 105
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 100
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. 92
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 75
Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection 66
Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients. 63
Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better 55
The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors : Pros and cons 48
Totale 737
Categoria #
all - tutte 1110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201818 0000 51 23 0043
2018/201973 121171 32 151 5664
2019/2020242 191230 1340 349 443587
2020/2021133 81235 514 520 2092012
2021/2022166 121929 1312 147 13261128
2022/2023105 22382017 80 00 0000
Totale 737